Three Bextra lawsuits were filed against Pfizer Inc. on behalf of three individuals who allegedly were injured by the pain relief drug, Bextra, the Philadelphia law firm Kline & Specter, P.C. announced Monday in a statement.
Two of the plaintiffs suffered heart attacks and one sustained a stroke after taking Bextra, attorneys for the plaintiffs stated.
Pfizer, [...]

A class action lawsuit was filed against Pfizer Inc., on behalf of all persons who died or were injured by the pain relief drug, Bextra, the Chicago law firm Kenneth B. Moll & Associates, Ltd. announced Monday.
The Bextra lawsuit accuses pharmaceutical giant Pfizer of failing to properly research the known risks of Bextra, warn consumers [...]

Pfizer Inc., the world’s largest drug maker, said Thursday it would remove the arthritis drug Bextra from the market. Following yesterday’s announcement, Louisiana attorneys for Bextra and Celebrex patients asked today a judicial panel in Washington, D.C. to move all Bextra and Celebrex lawsuits in the country to one federal court, the U.S. District Court [...]

Bextra, the pain relief drug from Pifzer Inc., was taken off the market Thursday because the overall risk versus benefit profile for Bextra is “unfavorable,” the Food and Drug Administration said.
Bextra belongs to a class of drugs called Cox-2 inhibitors, including Celebrex (made by Pfizer) and Vioxx (made by Merck & Company). All three painkillers [...]

A consumer group petitioned the Food and Drug Administration to remove the arthritis drugs Celebrex and Bextra from the market. The group claims that both painkillers from Pfizer Inc. increase the risk of heart attacks in patients.
Celebrex and Bextra are part of the same family of drugs called COX-2 inhibitors as Vioxx, which was pulled [...]

The “Powerful” arthritis drug Bextra from Pfizer will include a new warning about possible heart attack risk when used by patients who recently had heart bypass surgery, the Food and Drug Administration said on Thursday.
Bextra is part of the same family of drugs, COX-2 selective non-steroidal anti-inflammatory drug (NSAID), as Celebrex also made by Pfizer [...]

The “powerful” arthritis drug Bextra from drug giant Pfizer increases a patients’ risk of heart attack and stroke, according to preliminary results of a study presented yesterday at the American Heart Association meeting in New Orleans, the New York Times reported on Wednesday.
The study found that patients taking Bextra experienced twice the number of heart [...]

Pfizer, the world’s largest drugmaker, on Friday warned doctors that its arthritis drug Bextra might increase the risk of cardiovascular events, including heart attack or stroke, in coronary bypass surgery patients.
The news comes just two weeks after Merck pulled its arthritis drug Vioxx from all worldwide markets after a study confirmed that it increases [...]